Infectious Diseases

Welcome Message

Thanks and Regards,
Organizing Committee
Infectious Meet 2025
7th Global Experts Meeting on Infectious Diseases

About the Conference

The 7th Global Experts Meeting on Infectious Diseases, scheduled for December 15-16, 2025, in Barcelona, Spain, is a prestigious international platform bringing together leading researchers, clinicians, academicians, and industry experts from around the world. The conference is dedicated to advancing knowledge, fostering collaboration, and promoting innovative solutions in the prevention, diagnosis, and treatment of infectious diseases.

The two-day event will feature a series of scientific sessions, keynote presentations, panel discussions, and interactive workshops covering a wide range of topics including emerging infectious diseases, antimicrobial resistance, vaccine development, clinical management strategies, and public health interventions. Attendees will gain insights into the latest research breakthroughs, cutting-edge technologies, and global trends shaping the field of infectious diseases.

In addition to the academic program, the conference offers extensive networking opportunities, enabling participants to connect with peers, share experiences, and establish collaborations that drive future research and innovation. Whether you are a researcher, clinician, policymaker, or industry professional, this meeting provides a unique platform to engage with thought leaders and contribute to the global efforts in combating infectious diseases.

Join us in Barcelona for an inspiring and informative gathering that aims to advance scientific knowledge, improve patient care, and strengthen global partnerships in infectious disease research and management.

Why Attend the 7th Global Experts Meeting on Infectious Diseases

• Gain insights into the latest research, innovative treatments, and emerging infectious diseases.
• Connect and network with global experts, researchers, clinicians, and industry leaders.
• Participate in interactive workshops, panel discussions, and Q&A sessions.
• Enhance professional skills and knowledge for clinical practice, research, and public health.
• Understand global trends, challenges, and solutions in infectious disease management.
• Present your research and receive feedback from leading experts in the field.

Target Audience

• Researchers and scientists working in infectious diseases and microbiology.
• Clinicians, physicians, and healthcare professionals involved in patient care.
• Academicians, professors, and students in medical and life sciences.
• Public health officials and policymakers.
• Pharmaceutical and biotechnology industry professionals.
• Laboratory technicians and clinical researchers.
• Healthcare consultants and global health organizations.

Sessions and Tracks

Track 01. Emerging and Re-emerging Infectious Diseases

This track focuses on new threats and the resurgence of known ones.

• Key Topics:
  • Pandemic Preparedness and Response
  • Pathogen Discovery (e.g., novel viruses)
  • Outbreak Investigation and Genomics (e.g., using sequencing to track spread)
  • Zika, Ebola, Mpox (formerly Monkeypox), Avian Influenza
  • Antimicrobial Resistance (AMR) as a global emergency

Track 02. Respiratory Infections

Always a high-priority area, especially post-COVID-19.

• Key Topics:
  • COVID-19: Long COVID, variants, vaccines, therapeutics
  • Influenza: Seasonality, vaccine effectiveness, pandemic potential
  • Tuberculosis (TB): Drug-resistant TB, new diagnostics and treatments
  • Respiratory Syncytial Virus (RSV): vaccines and monoclonal antibodies
  • Pneumonia: Etiology, prevention, and management in all age groups

Track 03. Vector-Borne and Parasitic Diseases

Focuses on diseases transmitted by insects and other parasites.

• Key Topics:
  • Malaria: Vaccine rollout (RTS,S/AS01 and R21/Matrix-M), drug resistance, elimination strategies
  • Dengue, Chikungunya, and Zika: Epidemiology, control measures, vaccines
  • Neglected Tropical Diseases (NTDs): Schistosomiasis, Leishmaniasis, Chagas disease
  • Lyme Disease and other tick-borne illnesses

Track 04. Healthcare-Associated Infections (HAIs) and Antimicrobial Stewardship

Focuses on infections acquired in healthcare settings and the fight against resistance.

• Key Topics:
  • MRSA, VRE, and other multi-drug resistant organisms
  • Clostridioides difficile Infections
  • Infection Prevention and Control (IPC) practices
  • Antimicrobial Stewardship Programs: Strategies to optimize antibiotic use
  • Diagnostics for rapid detection of resistance

Track 05. Sexually Transmitted Infections (STIs) and Blood-Borne Viruses

• Key Topics:
  • HIV: Prevention (PrEP, vaccines), treatment, cure research, implementation science
  • Hepatitis B and C: Elimination goals, treatment access, mother-to-child transmission
  • Syphilis: The ongoing global surge, congenital syphilis
  • Mpox (Monkeypox): Epidemiology in new contexts

Track 06. Viral Hepatitis

Often has its own dedicated track due to its global burden and elimination goals.

• Key Topics:
  • Hepatitis C: Point-of-care testing, simplifying treatment, managing advanced disease
  • Hepatitis B: Functional cure research, new antiviral therapies, prevention of vertical transmission
  • Elimination Strategies: Micro-elimination in key populations

Track 07. Diagnostics, Microbiology, and Laboratory Science

The foundational track for identifying and understanding pathogens.

• Key Topics:
  • Next-Generation Sequencing (NGS) in public health
  • Rapid Molecular Diagnostics and Point-of-Care Testing
  • Bioinformatics and Pathogen Genomics
  • Serology and Immunoassays
  • Mycobacteriology (for TB)

Track 08. Vaccinology and Immunization

Critical for the prevention of infectious diseases.

• Key Topics:
  • Vaccine Development (e.g., for HIV, Universal Flu)
  • Vaccine Safety and Pharmacovigilance
  • Vaccine Hesitancy and Demand
  • Delivery Strategies and Equity (e.g., COVAX)
  • Maternal Immunization

Track 09. Therapeutics and Clinical Management

Focuses on the treatment of infected individuals.

• Key Topics:
  • Clinical Trials for new antivirals, antibiotics, and antifungals
  • Management of Severe Sepsis and Septic Shock
  • Outpatient Treatment Paradigms (e.g., for COVID-19)
  • Managing Complex Infections (e.g., in immunocompromised hosts)

Track 10. One Health and Zoonoses

An interdisciplinary track recognizing the connection between human, animal, and environmental health.

• Key Topics:
  • Spillover events: How animal diseases jump to humans
  • Surveillance in wildlife and livestock
  • Climate Change and its impact on disease distribution
  • Food Safety and Security

Track 11: Clinical Trials and Novel Therapeutics

This track is dedicated to the research and development of new treatments, from the lab bench to the patient bedside.

• Key Topics:
  • Phase I-III trial designs for antivirals, antibiotics, and antifungals
  • Repurposing existing drugs for new infectious indications
  • Monoclonal antibodies and immunotherapies
  • Challenges in conducting clinical trials during outbreaks
  • Endpoint selection for antimicrobial efficacy

Track 12: Tuberculosis

Focus: Comprehensive coverage of the ongoing global fight against Mycobacterium tuberculosis, from basic science to public health implementation.

• Key Topics:
  • Diagnostics: Development and rollout of rapid molecular tests (e.g., GeneXpert), non-sputum-based biomarkers, and tests for latent TB.
  • Treatment: Management of drug-sensitive and drug-resistant TB (MDR/XDR-TB), shorter-duration treatment regimens, and management of treatment complications.
  • Prevention: TB infection control strategies, preventive therapy for latent TB, and BCG vaccine research and new vaccine development.
  • Special Populations: TB in children, TB/HIV co-infection, and comorbidities.
  • Global Health: Epidemiology, national TB program strategies, and the WHO's End TB strategy.

Track 13: Herpes Simplex Virus

Focus: Clinical management, virology, and public health aspects of HSV-1 and HSV-2 infections.

• Key Topics:
  • Clinical Manifestations: Genital herpes, orolabial herpes, herpes keratitis, whitlow, and neonatal herpes.
  • Treatment and Suppression: Antiviral therapy (acyclovir, valacyclovir), managing recurrent outbreaks, and addressing antiviral resistance.
  • Transmission and Prevention: Sexual transmission dynamics, mother-to-child transmission prevention, and condom/antiviral use as prevention.
  • Virology and Latency: Mechanisms of viral latency and reactivation in neuronal ganglia.
  • Vaccine Development: Current status and challenges in developing a prophylactic HSV vaccine.

Track 14: Food Pathology

Focus: The study of pathogens that contaminate food, causing illness, and the systems to ensure food safety.

• Key Topics:
  • Major Pathogens: Salmonella spp., E. coli (STEC), Listeria monocytogenes, Campylobacter jejuni, and Vibrio species.
  • Outbreak Investigation: Traceback methods, whole genome sequencing for source identification, and cluster analysis.
  • Toxins and Virulence Factors: Bacterial toxins (e.g., Shiga toxin, staphylococcal enterotoxin) and their mechanisms of action.
  • Food Safety Systems: HACCP (Hazard Analysis Critical Control Point), regulatory standards, and microbiological testing of food products.
  • Emerging Threats: Antimicrobial resistance in foodborne pathogens and the impact of global food supply chains.

Track 15: Diarrheal Diseases

Focus: The causes, consequences, and interventions for infectious diarrhea, a leading cause of global childhood mortality.

• Key Topics:
  • Etiological Agents: Viral (Rotavirus, Norovirus), Bacterial (E. coli, Shigella, Vibrio cholerae, Campylobacter), and Parasitic (Cryptosporidium, Giardia).
  • Pathogenesis: Mechanisms of diarrhea production (toxin-mediated, invasive, osmotic).
  • Management: Oral rehydration therapy (ORT), zinc supplementation, and appropriate antibiotic use.
  • Prevention: Vaccination (Rotavirus, cholera), Water, Sanitation, and Hygiene (WASH) initiatives, and breastfeeding promotion.
  • Global Burden: Epidemiology in low-resource settings and long-term impacts (malnutrition, developmental delays).

Track 16: Antimicrobial Drugs

Focus: The development, use, and preservation of agents used to treat bacterial, fungal, viral, and parasitic infections.

• Key Topics:
  • Drug Discovery: The antibiotic pipeline, novel targets for new antibiotics, antifungals, and antivirals.
  • Mechanisms of Action and Resistance: How drugs work and how pathogens evolve to resist them.
  • Pharmacokinetics/Pharmacodynamics (PK/PD): Optimizing dosing strategies for efficacy and preventing resistance.
  • Clinical Use: Guidelines for empiric and targeted therapy for various syndromes.
  • Access and Stewardship: Balancing the need for access to antibiotics with the imperative to use them responsibly to curb resistance.

Track 17: Molecular Diagnosis of Infectious Diseases

Focus: The use of nucleic acid-based technologies to detect, identify, and characterize pathogens.

• Key Topics:
  • PCR and Variants: Multiplex PCR, quantitative PCR (qPCR), and digital PCR for pathogen detection and load monitoring.
  • Next-Generation Sequencing (NGS): Whole genome sequencing for outbreak investigation, transmission tracking, and resistance prediction.
  • Point-of-Care Molecular Tests: Rapid, cartridge-based systems for use in clinic or field settings.
  • Syndromic Panels: Multiplexed tests for respiratory, gastrointestinal, and bloodstream infections.
  • Bioinformatics: Tools and pipelines for analyzing complex genomic data from pathogens.

Track 18: Social Behavior on Infectious Diseases

Focus: Understanding how human behavior, social structures, and cultural contexts influence the spread and control of infections.

• Key Topics:
  • Vaccine Hesitancy and Uptake: Drivers of hesitancy, effective communication strategies, and building trust.
  • Adherence to Public Health Measures: Factors influencing adherence to masking, testing, isolation, and treatment.
  • Stigma: The impact of stigma (e.g., around HIV, TB, MPOX) on testing, treatment, and disclosure.
  • Social Determinants of Health: How poverty, education, housing, and racism affect vulnerability and outcomes.
  • Community Engagement: Participatory approaches to designing and implementing effective public health interventions.

Track 19: AI-Powered Predictive Outbreak Analytics

Focus: Using machine learning and big data to forecast, model, and mitigate the spread of infectious diseases.

• Key Topics:
  • Epidemic Forecasting: Developing ML models to predict outbreak trajectories, hotspots, and resurgence of pathogens like influenza, dengue.
  • Early Warning Systems: Integrating disparate data sources (e.g., wastewater surveillance, internet search trends, climate data, flight patterns) for early signal detection.
  • One Health Surveillance: Applying AI to analyze data from animal populations, environmental sensors, and human health records to predict zoonotic spillover events.
  • Evaluating Intervention Impact: Simulating and forecasting the effects of public health interventions (e.g., travel restrictions, lockdowns) before implementation.

Track 20: AI in Diagnostic Microbiology and Genomics

Focus: Revolutionizing pathogen detection, identification, and characterization through artificial intelligence.

• Key Topics:
  • Digital Pathology and Microscopy: Using deep learning algorithms to automatically detect pathogens (e.g., malaria parasites, TB bacilli) in blood smears, sputum samples, and tissue biopsies.
  • Genomic Interpretation: Deploying AI tools for rapid analysis of next-generation sequencing data to identify species, predict antimicrobial resistance markers, and trace transmission chains.
  • Syndromic Diagnostic Support: Developing AI-based clinical decision support systems that integrate patient symptoms, lab results, and exposure history to suggest likely diagnoses.
  • Metagenomics: Utilizing machine learning to identify known and novel pathogens directly from complex clinical samples (e.g., blood, CSF).

Market Size & Growth

• 2024: Valued at USD 25.01 billion
• 2025: Projected to reach USD 27.43 billion
• 2034: Expected to grow to USD 62.95 billion, with a CAGR of 9.67% from 2025 to 2034 

The global infectious disease market is projected to experience significant growth over the next five years, driven by increasing prevalence of infectious diseases, rising awareness of early diagnosis, technological advancements, and pandemic preparedness measures. The infectious disease diagnostics segment, valued at approximately USD 25 billion in 2024, is expected to reach USD 27.43 billion by 2025 and continue to grow to nearly USD 63 billion by 2034, reflecting a compound annual growth rate of 9.67 percent. This growth is largely fueled by innovations in molecular diagnostics, point-of-care testing, and rapid detection techniques that improve accuracy and reduce turnaround time. North America currently dominates the market due to robust healthcare infrastructure and high disease burden, while Asia-Pacific is expected to witness the fastest growth owing to increasing healthcare investments and rising prevalence of infectious diseases. The therapeutics segment, estimated at USD 72.5 billion in 2025, is projected to reach USD 101 billion by 2030 at a CAGR of 6.9 percent, driven by the growing threat of antimicrobial resistance, the development of novel vaccines, and the increasing adoption of biologics and biosimilars. In the molecular diagnostics segment, valued at USD 15.85 billion in 2024, the market is expected to reach USD 22.45 billion by 2035, supported by advancements in precision medicine and the integration of diagnostics with digital health platforms. Across all segments, key trends include the use of artificial intelligence and machine learning to enhance diagnostic accuracy and treatment outcomes, expansion of telemedicine and remote monitoring services, and international collaborations to strengthen global infectious disease control initiatives. Overall, the market outlook is highly positive, with substantial opportunities for innovation, investment, and strategic growth in diagnostics, therapeutics, and digital health solutions for infectious disease management.

Future Outlook & Strategic Insights

Integration of AI & ML: Artificial Intelligence and Machine Learning are increasingly being utilized to enhance diagnostic accuracy and therapeutic efficacy.

Telemedicine & Remote Monitoring: The adoption of telemedicine is expanding access to infectious disease management, especially in remote areas.

Global Health Initiatives: International collaborations and funding are bolstering efforts to combat infectious diseases globally.

In addition to the growth in diagnostics and therapeutics, the infectious disease market is being shaped by emerging technologies and digital health solutions that enhance disease monitoring and management. The integration of wearable devices, mobile health applications, and cloud-based platforms is enabling real-time tracking of infections and improving patient engagement, especially in remote or underserved regions. Furthermore, the increasing focus on personalized medicine and genomics is driving the development of targeted therapies, allowing healthcare providers to tailor treatments based on individual patient profiles. Public and private sector investments in research and development, coupled with government initiatives to strengthen surveillance and outbreak response, are expected to accelerate innovation and adoption of advanced solutions. Overall, these trends indicate a robust and dynamic market, presenting significant opportunities for stakeholders across diagnostics, therapeutics, digital health, and preventive care over the next five years.

Important Deadlines

• Abstract Submission Deadline: November 30, 2025
• Early Bird Registration Deadline: October 30, 2025
• Regular Registration Deadline: December 14, 2025

For any assistance or queries regarding submissions or registration, kindly contact us at contact@speakermeeting.com

Past Conference Report

Infectious Meet 2023

World Congress on Infectious meet  invites all the participants across the globe to attend and share their insights and convey recent development technologies and methodologies on 6th Global Experts Meeting on Infectious Diseases based on the theme “ Infectious Disease is an Era of Global Change” which will be held during August 07-08, 2023 Singapore City, Singapore  We are pleased to welcome all Virologists, Scientists, Delegates, Speakers, dermatologists, pulmonologist, and primary health care doctors for infectious meet to attend the  conference.

Today, there are over seven billion people on the planet, and whether directly or indirectly through global pollution and climate changes, our actions have an effect on every aspect of it. This conference is how anthropogenic environmental changes negatively affect human health by increasing the dangers of infectious diseases, natural disasters, food and water scarcity, as well as natural disasters and population migration. In the case of infectious diseases perceived as tropical, like malaria, socioeconomic variables may be substantially more crucial than climate. The effects of illness may also include a vicious cycle in which the diseases worsen poverty, which makes the poor more susceptible to illnesses. Particularly arboviruses tend to disproportionately affect the impoverished and may cost both families and societies in the form of long-lasting aftereffects. Numerous illnesses can also be fatal right away, which causes people without access to medical care to become sick during the viral or parasite phases, increasing their susceptibility to further bites from vectors and increasing the rate of infection in the vectors.